"moderate" MCQ (SBA): Endocrinology

Instant feedback + full explanation. One question, done properly.

Moderate"ADA Standards recommend SGLT2 inhibitors for CKD with albuminuria and adequate eGFR to slow progression and reduce CV events. Other options lack proven kidney‑protective effects."Endocrinology"moderate"

A 44-year-old with early type 2 diabetes and CKD (eGFR 48, UACR 380 mg/g) on metformin and ACE inhibitor. Per ADA 2025, which therapy is specifically recommended to slow CKD progression?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

"moderate" MCQ: Endocrinology — Answer & Explanation | iatroX